The global Duchenne Muscular Dystrophy drugs market is advancing with gene therapies like Sarepta’s Elevidys, expanding exon-skipping treatments, and AI-driven drug development. Growing awareness and newborn screening initiatives boost demand, while combination therapies enhance patient outcomes.
Duchenne Muscular Dystrophy Drugs Market Report, 2033
The global Duchenne muscular dystrophy drugs market size reached USD 2.5 Billion in 2024 and grow at a CAGR of 9.46% to reach USD 5.9 Billion by 2033.
https://www.imarcgroup.com/duchenne-muscular-dystrophy-drugs-market
11:08 AM - Jul 16, 2025 (UTC)
